EC Neurology

Review Article Volume 16 Issue 10 - 2024

Stroke Pathogenesis: Unravelling the Complex Interplay of Autophagy, Oxidative Stress, and Inflammation

Onyinoyi Bethel Onimisi1, Moses Ibrahim Auza2, Joy Ochai3, Stephen Samuel Lazarus4, James Bolaji Promise5, Helena Fodeke6, Muhammad Shehu Hassan6 and Wusa Makena7

1Department of Anatomy, Faculty of Basic Medical Science, Usmanu Danfodiyo University, Sokoto, Nigeria
2Department of Anatomy, Faculty of Basic Medical Science, College of Medicine and Allied Health Sciences, Bingham University Karu, Nasarawa State, Nigeria
3Department of Anatomy, College of Basic Medical Sciences, Federal University of Health Sciences, Otukpo, Benue State, Nigeria
4Department of Basic Medical Science, Faculty of Basic Medical and Health Sciences, New Gate University, Minna, Nigeria
5Department of Nursing Science, College of Health, Joseph Ayo Babalola University, Nigeria
6Department of Public Health, Ahmadu Bello University, Zaria, Nigeria
7Department of Anatomy, Faculty of Basic Medical Science, Kampala International University, Western Campus, Bushenyi, Uganda

*Corresponding Author: Moses I Auza, Department of Human Anatomy, Faculty of Basic Medical Sciences, Bingham University Karu, Nigeria.
Received: August 22, 2024; Published: September 25, 2024



Stroke has caused far more deaths and disabilities than any other health problem, necessitating a comprehensive understanding of its pathophysiology that is crucial to developing effective therapeutic strategies. This review paper examines the complex relationship between stroke, autophagy, oxidative stress and inflammation highlighting their involvement in neuronal injury and therapy. The role that autophagy plays in stroke can be seen in different lights as it can either protect cells by removing damaged organelles or cause cell death when certain conditions prevail. Stroke pathogenesis is determined by major pathways, such as mTOR, NF-κB, and HIF-1, as well as their relationship to ischemic and pro-inflammatory responses. Oxidative stress in stoke, primarily caused by an imbalance in reactive oxygen species (ROS), is a major factor in neuronal damage caused by mitochondrial dysfunction and lipid peroxidation. The significance of antioxidant therapy is an increase in stroke management with oxidative stress as the mediator of cell death. Activation of microglial cells and release of cytokines resulting in inflammatory upsurge increase tissue damage after stroke. Inflammatory response combined with overactive autophagy/oxidative stress may heighten the severity of cerebrovascular disease; thus, neuroprotection can be significantly achieved through maintaining brain antioxidant and anti-inflammatory activities while responding to injury. Obstacles including translation gaps and individual variations in treatment response necessitate more research to clarify the signaling pathways' roles and identify new therapeutic targets.

Keywords: Ischemia; Stroke; Autophagy; Inflammation; Oxidative Stress; Neurodegeneration

  1. Feigin Valery L., et al. “World Stroke Organization (WSO): global stroke fact sheet 2022”. International Journal of Stroke1 (2022): 18-29.
  2. World Stroke Organization. “Global Stroke Fact Sheet”. World Stroke Organization (2022).
  3. Feigin Valery L., et al. “Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010”. The Lancet9913 (2014): 245-255.
  4. Stanzione Rosita., et al. “Role of autophagy in ischemic stroke: insights from animal models and preliminary evidence in the human disease”. Frontiers in Cell and Developmental Biology12 (2024): 1360014.
  5. Dirnagl Ulrich., et al. "Pathobiology of ischaemic stroke: an integrated view”. Trends in Neurosciences9 (1999): 391-397.
  6. Kalogeris Theodore., et al. “Ischemia/reperfusion”. Comprehensive Physiology1 (2016): 113.
  7. Hemphill III J Claude., et al. “Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association”. Stroke7 (2015): 2032-2060.
  8. Wang Pei., et al. “Autophagy in ischemic stroke”. Progress in Neurobiology163 (2018): 98-117.
  9. Liu Y., et al. “Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia”. Autophagy3 (2019): 493-509.
  10. Sies Helmut. "Oxidative stress: a concept in redox biology and medicine”. Redox Biology4 (2015): 180-183.
  11. Chamorro Ángel., et al. “Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation”. The Lancet Neurology8 (2016): 869-881.
  12. Perez-Alvarez Maria J., et al. “Role of mTORC1 controlling proteostasis after brain ischemia”. Frontiers in Neuroscience12 (2018): 60.
  13. Hu Zhiping., et al. “Mechanism and regulation of autophagy and its role in neuronal diseases”. Molecular Neurobiology3 (2015): 1190-1209.
  14. He Jialin., et al. “Oxidative stress, inflammation, and autophagy: potential targets of mesenchymal stem cell-based therapies in ischemic stroke”. Frontiers in Neuroscience15 (2021): 641157.
  15. George Paul M and Gary K Steinberg. "Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments”. Neuron2 (2015): 297-309.
  16. Shi Zhuolu., et al. “A bibliometric analysis of research foci and trends in cerebral ischemia-reperfusion injury involving autophagy from 2008 to 2022”. Medicine47 (2023): e35961.
  17. Gómez-Virgilio Laura., et al. “Autophagy: a key regulator of homeostasis and disease: an overview of molecular mechanisms and modulators”. Cells15 (2022): 2262.
  18. Wang Xiaoyu., et al. “An updated review of autophagy in ischemic stroke: From mechanisms to therapies”. Experimental Neurology340 (2021): 113684.
  19. Laplante Mathieu and David M Sabatini. "mTOR signaling in growth control and disease”. Cell2 (2012): 274-293.
  20. Xu Dan-Dan and Li-Lin Du. "Fission yeast autophagy machinery”. Cells7 (2022): 1086.
  21. Marino G., et al. “Caloric restriction mimetics: natural/physiological pharmacological autophagy inducers”. Autophagy11 (2014): 1879-1882.
  22. Dai Shu-Hui., et al. “Sirt3 confers protection against neuronal ischemia by inducing autophagy: involvement of the AMPK-mTOR pathway”. Free Radical Biology and Medicine108 (2017): 345-353.
  23. Garcia Daniel and Reuben J Shaw. "AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance”. Molecular Cell6 (2017): 789-800.
  24. Deng Yang., et al. “Astrocyte-derived exosomal nicotinamide phosphoribosyltransferase (Nampt) ameliorates ischemic stroke injury by targeting AMPK/mTOR signaling to induce autophagy”. Cell Death and Disease12 (2022): 1057.
  25. Carloni Silvia., et al. "Protective role of autophagy in neonatal hypoxia-ischemia-induced brain injury”. Neurobiology of Disease3 (2008): 329-339.
  26. Wu Meiling., et al. “Rapamycin prevents cerebral stroke by modulating apoptosis and autophagy in penumbra in rats”. Annals of Clinical and Translational Neurology2 (2018): 138-146.
  27. Yu Jing., et al. “Ezetimibe, a NPC1L1 inhibitor, attenuates neuronal apoptosis through AMPK dependent autophagy activation after MCAO in rats”. Experimental Neurology307 (2018): 12-23.
  28. Papadakis Michalis., et al. “Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy”. Nature Medicine3 (2013): 351-357.
  29. Qi Zhifeng., et al. “Bcl-2 phosphorylation triggers autophagy switch and reduces mitochondrial damage in limb remote ischemic conditioned rats after ischemic stroke”. Translational Stroke Research3 (2015): 198-206.
  30. Feng Dayun., et al. “Pre‐ischemia melatonin treatment alleviated acute neuronal injury after ischemic stroke by inhibiting endoplasmic reticulum stress‐dependent autophagy via PERK and IRE 1 signaling”. Journal of Pineal Research3 (2017): e12395.
  31. Maiuri M Chiara., et al. “Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1”. The EMBO Journal10 (2007): 2527-2539.
  32. Marquez Rebecca T and Liang Xu. "Bcl-2: Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch”. American Journal of Cancer Research2 (2012): 214-221.
  33. Liang C. "Negative regulation of autophagy”. Cell Death and Differentiation12 (2010): 1807-1815.
  34. Krishnan Sharmeelavathi., et al. “Activate or inhibit? Implications of autophagy modulation as a therapeutic strategy for Alzheimer’s disease”. International Journal of Molecular Sciences18 (2020): 6739.
  35. Zhou Daixuan., et al. “Circular RNA 0025984 ameliorates ischemic stroke injury and protects astrocytes through miR-143-3p/TET1/ORP150 pathway”. Molecular Neurobiology11 (2021): 5937-5953.
  36. Jiang Jin., et al. "Vitexin reverses the autophagy dysfunction to attenuate MCAO-induced cerebral ischemic stroke via mTOR/Ulk1 pathway”. Biomedicine and Pharmacotherapy99 (2018): 583-590.
  37. Frati Giacomo., et al. "Novel beneficial cardiovascular effects of natural activators of autophagy”. Circulation Research8 (2018): 947-949.
  38. Carnevale Roberto., et al. “Beneficial effects of a combination of natural product activators of autophagy on endothelial cells and platelets”. British Journal of Pharmacology10 (2021): 2146-2159.
  39. Forte Maurizio., et al. “Trehalose, a natural disaccharide, reduces stroke occurrence in the stroke-prone spontaneously hypertensive rat”. Pharmacological Research173 (2021): 105875.
  40. Shoji-Kawata Sanae., et al. “Identification of a candidate therapeutic autophagy-inducing peptide”. Nature7436 (2013): 201-206.
  41. Forte Maurizio., et al. “Pharmacological restoration of autophagy reduces hypertension-related stroke occurrence”. Autophagy8 (2020): 1468-1481.
  42. Forte Maurizio., et al. “NPPA/atrial natriuretic peptide is an extracellular modulator of autophagy in the heart”. Autophagy4 (2023): 1087-1099.
  43. Saumya Pandey. “CRISPR-Cas gene-editing for precision-medicine based “neuro-oncogenomics” in immunotherapeutic targeting of Wnt/frizzled-toll like receptors-autophagy: cost-effective management of schizophrenia, obsessive compulsive disorder, alzheimer’s disease and glioblastoma in genetically disparate susceptible population-pools in in the covid-19 vaccination era”. EC Clinical and Medical Case Reports2 (2023): 12-14.
  44. Cui J., et al. “CRISPR system for genome engineering: the application for autophagy study”. BMB Reports5 (2017): 247-256.
  45. Johnstone Mandy., et al. "A central role for astrocytes in the inflammatory response to β-amyloid; chemokines, cytokines, and reactive oxygen species are produced”. Journal of Neuroimmunology1-2 (1999): 182-193.
  46. Adang Laura A., et al. “Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies”. Molecular Genetics and Metabolism1-2 (2017): 18-32.
  47. Banerjee Sharmistha., et al. “ROS-associated immune response and metabolism: a mechanistic approach with implication of various diseases”. Archives of Toxicology7 (2020): 2293-2317.
  48. Ogawa Yasuhiro., et al. “Reactive oxygen species-producing site in hydrogen peroxide-induced apoptosis of human peripheral T cells: involvement of lysosomal membrane destabilization”. International Journal of Molecular Medicine5 (2004): 655-660.
  49. Ishikawa Kazunobu., et al. “Increased reactive oxygen species and anti-oxidative response in mitochondrial cardiomyopathy”. Circulation Journal5 (2005): 617-620.
  50. Yang Xinyu., et al. “Oxidative stress-mediated atherosclerosis: mechanisms and therapies”. Frontiers in Physiology8 (2017): 600.
  51. Wu Xiaolin., et al. “CARD3 promotes cerebral ischemia‐reperfusion injury via activation of TAK1”. Journal of the American Heart Association9 (2020): e014920.
  52. Saeed Sheikh Arshad., et al. “Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke”. Experimental Brain Research1 (2007): 1-10.
  53. Menon Bindu., et al. "Evaluating the role of oxidative stress in acute ischemic stroke”. Journal of Neurosciences in Rural Practice01 (2020): 156-159.
  54. Tiwari Shashi., et al. "Inflammation, oxidative stress, and cerebral stroke: Basic principles”. Advancement in the Pathophysiology of Cerebral Stroke (2019): 11-21.
  55. Lochhead Jeffrey J., et al. "The role of oxidative stress in blood-brain barrier disruption during ischemic stroke: Antioxidants in clinical trials”. Biochemical Pharmacology30 (2024): 116186.
  56. Chavda Vishal., et al. “Molecular mechanisms of oxidative stress in stroke and cancer”. Brain Disorders5 (2022): 100029.
  57. Yoo Joonsang., et al. “The frequency and risk of preclinical coronary artery disease detected using multichannel cardiac computed tomography in patients with ischemic stroke”. Cerebrovascular Diseases3 (2012): 286-294.
  58. Jayaraj Richard L., et al. “Neuroinflammation: friend and foe for ischemic stroke”. Journal of Neuroinflammation1 (2019): 142.
  59. Kettenmann Helmut., et al. “Physiology of microglia”. Physiological Reviews2 (2011): 461-553.
  60. Degan Diana., et al. “The role of inflammation in neurological disorders”. Current Pharmaceutical Design14 (2018): 1485-1501.
  61. Pandey Saumya. "IL-6-induced upregulation of T-type Ca2+ currents and sensitization of DRG nociceptors is attenuated by MNK inhibition: translational research perspective”. Journal of Neurophysiology1 (2020): 305-306.
  62. Planas Anna M. "Role of immune cells migrating to the ischemic brain”. Stroke9 (2018): 2261-2267.
  63. Zhang Yun., et al. “The role of MAPK in the regulation of autophagy in ischemic stroke”. Journal of Neurochemistry5 (2018): 1-12.
  64. Inoki Ken., et al. “TSC2 mediates cellular energy response to control cell growth and survival”. Journal of Cell Biology3 (2002): 453-464.
  65. Zhao Yongting., et al. “Autophagy and its role in ischemic stroke”. Frontiers in Neuroscience 12 (2018): 1-11.
  66. Zhou Yongbo., et al. “NLRP3 inflammasome activation and neuroinflammation in ischemic stroke”. Frontiers in Immunology 10 (2019): 1-12
  67. Tang Yongjun., et al. “The role of autophagy in the polarization of microglia in neuroinflammation”. Frontiers in Cellular Neuroscience 13 (2019): 1-10.
  68. Li Yue., et al. “Autophagy and NF-κB Signaling in Neuroinflammation”. Journal of Neuroinflammation1 (2018): 1-12
  69. Mo Yun., et al. "Autophagy and inflammation in ischemic stroke”. Neural Regeneration Research8 (2020): 1388-1396.
  70. Ajoolabady Amir., et al. “Targeting autophagy in ischemic stroke: from molecular mechanisms to clinical therapeutics”. Pharmacology and Therapeutics225 (2021): 107848.
  71. Pourhanifeh Mohammad H., et al. “The effect of resveratrol on neurodegenerative disorders: possible protective actions against autophagy, apoptosis, inflammation and oxidative stress”. Current Pharmaceutical Design19 (2019): 2178-2191.
  72. Wang Xin., et al. “Resveratrol protects against ischemic stroke injury by modulating autophagy and inflammation”. Neuroscience Letters 731 (2020): 134956.
  73. Iadecola Costantino and Josef Anrather. "The immunology of stroke: from mechanisms to translation”. Nature Medicine7 (2011): 796-808.
  74. Neves Sofia Pereira das. "Exploring the role of astrocytes in the pathophysiology of multiple sclerosis”. (2021).
  75. Onimisi O., et al. “Anti-inflammatory and anti-cholinesterase potentials of computational drug design-guided phenolics fraction of Tetrapleura Tetraptera fruit on cerebral ischemia in adult male Wistar rats”. International Journal of Stroke3 (2023): 349-349.
  76. Jonas T. “The role of microglia in cognitive function”. Frontiers in Neuroscience 14 (2022): 123-135.
  77. Macrez Richard., et al. “Stroke and the immune system: from pathophysiology to new therapeutic strategies”. The Lancet Neurology5 (2011): 471-480.
  78. Deretic Vojo., et al. "Autophagy in infection, inflammation and immunity”. Nature Reviews Immunology10 (2013): 722-737.
  79. Pickrell Alicia M and Richard J Youle. "The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease”. Neuron2 (2015): 257-273.
  80. CS SHI. "Activation of autophagy by inflammatory signals limits IL-1b production by targeting ubiquitinated inflammasomes for destruction”. Nature Immunology3 (2012): 255-263.
  81. Scherz-Shouval Ruth and Zvulun Elazar. "ROS, mitochondria and the regulation of autophagy”. Trends in Cell Biology 9 (2007): 422-427.
  82. Mizushima Noboru and Beth Levine. "Autophagy in mammalian development and differentiation”. Nature Cell Biology9 (2010): 823-830.
  83. Liu Ting., et al. “NF-κB signaling in inflammation”. Signal Transduction and Targeted Therapy2 (2017): 17023.
  84. Maiese Kenneth., et al. “Targeting disease through novel pathways of apoptosis and autophagy”. Expert Opinion on Therapeutic Targets12 (2012): 1203-1214.
  85. Verma Gaurav and Malabika Datta. "The critical role of JNK in the ER‐mitochondrial crosstalk during apoptotic cell death”. Journal of Cellular Physiology5 (2012): 1791-1795.
  86. Ren Jia-Xin., et al. “Crosstalk between oxidative stress and ferroptosis/oxytosis in ischemic stroke: possible targets and molecular mechanisms”. Oxidative Medicine and Cellular Longevity(2021): 6643382.
  87. Saleem Suraiya. "Apoptosis, autophagy, necrosis and their multi galore crosstalk in neurodegeneration”. Neuroscience469 (2021): 162-174.
  88. Liddell Jeffrey R and Anthony R White. "Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease”. Neurochemistry International117 (2018): 126-138.
  89. Galluzzi Lorenzo., et al. “Molecular definitions of autophagy and related processes”. The EMBO Journal13 (2017): 1811-1836.
  90. Testa Gabriella., et al. “Calorie restriction and dietary restriction mimetics: a strategy for improving healthy aging and longevity”. Current Pharmaceutical Design18 (2014): 2950-2977.
  91. Forman Henry Jay and Hongqiao Zhang. "Targeting oxidative stress in disease: promise and limitations of antioxidant therapy”. Nature Reviews Drug Discovery9 (2021): 689-709.
  92. Uttara Bayani., et al. “Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options”. Current Neuropharmacology1 (2009): 65-74.
  93. Jurcau Anamaria. "The role of natural antioxidants in the prevention of dementia—Where do we stand and future perspectives”. Nutrients2 (2021): 282.
  94. Mittal Pooja., et al. “A review on natural antioxidants for their role in the treatment of Parkinson’s disease”. Pharmaceuticals7 (2023): 908.
  95. Lucas Sian‐Marie., et al. "The role of inflammation in CNS injury and disease”. British Journal of PharmacologyS1 (2006): S232-S240.
  96. Michael-Titus Adina T and John V Priestley. "Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity?”. Trends in Neurosciences1 (2014): 30-38.
  97. Vakifahmetoglu-Norberg Helin., et al. "Pharmacologic agents targeting autophagy”. The Journal of Clinical Investigation1 (2015): 5-13.
  98. Limanaqi Fiona., et al. “Phytochemicals bridging autophagy induction and alpha-synuclein degradation in parkinsonism”. International Journal of Molecular Sciences13 (2019): 3274.
  99. Shirley Rachel., et al. "Oxidative stress and the use of antioxidants in stroke”. Antioxidants3 (2014): 472-501.
  100. Firuzi O., et al. “Antioxidant therapy: current status and future prospects”. Current Medicinal Chemistry25 (2011): 3871-3888.
  101. Shan Hailei., et al. “Safety and efficacy of edaravone for patients with acute stroke: A protocol for randomized clinical trial”. Medicine8 (2021): e24811.
  102. Mallah Khalil., et al. “Anti-inflammatory and neuroprotective agents in clinical trials for CNS disease and injury: where do we go from here?" Frontiers in Immunology11 (2020): 2021.
  103. Drieu Antoine., et al. “Anti-inflammatory treatments for stroke: from bench to bedside”. Therapeutic Advances in Neurological Disorders11 (2018): 1756286418789854.

Onyinoyi Bethel Onimisi., et al. “Stroke Pathogenesis: Unravelling the Complex Interplay of Autophagy, Oxidative Stress, and Inflammation”. EC Neurology  16.10 (2024): 01-19.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net